Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks
Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks · The Wall Street Journal

In This Article:

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor concerns.

Waiting for permission
Allow microphone access to enable voice search

Try again.